Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bert-Jan H van den Born

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|December 3, 2014
Blood pressure lowering and cardiovascular riskBert-Jan H van den Born
Journal of Clinical Hypertension (Greenwich, Conn.)|October 3, 2020
Funduscopy in hypertensive emergencies: Detecting flames in the cotton fieldsFouad Amraoui, Bert-Jan H van den Born
Nederlands Tijdschrift Voor Geneeskunde|February 20, 2020
[Morning or evening; What is the best time to take antihypertensive drugs?]Rik H G Olde Engberink, Bert-Jan H van den Born
Journal of Clinical Hypertension (Greenwich, Conn.)|November 1, 2019
Blood pressure lowering treatment and the Framingham score: Do not fear riskTom F Brouwer, Didier Collard, Bert-Jan H van den Born
JAMA Internal Medicine|October 5, 2018
Hydrochlorothiazide and the Risk of Malignant MelanomaBert-Jan H van den Born, Rik Olde-Engberink, Liffert Vogt
Journal of Human Hypertension|September 25, 2019
Effect of self-initiated and fully-automated self-measurement on blood pressureRosanne T Berkhof, Katia Gazzola, Bert-Jan H van den Born
European Heart Journal|April 8, 2025
Gut microbiota as predictors of recurrent cardiovascular events: challenges and future directionsBarbara J H Verhaar, Max Nieuwdorp, Bert-Jan H van den Born
Current Opinion in HIV and AIDS|August 9, 2017
Hypertension in people living with HIVRosan A van Zoest, Bert-Jan H van den Born, Peter Reiss
Circulation|June 6, 2018
Response by Kalkman et al to Letter Regarding Article, "J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm"Deborah N Kalkman, Tom F Brouwer, Bert-Jan H van den Born
Current Opinion in Lipidology|December 17, 2020
Impact drugs targeting cardiometabolic risk on the gut microbiotaManon Balvers, Bert-Jan H van den Born, Evgeni Levin, et al.
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|December 3, 2014
Blood pressure lowering and cardiovascular riskBert-Jan H van den Born
Journal of Clinical Hypertension (Greenwich, Conn.)|October 3, 2020
Funduscopy in hypertensive emergencies: Detecting flames in the cotton fieldsFouad Amraoui, Bert-Jan H van den Born
Nederlands Tijdschrift Voor Geneeskunde|February 20, 2020
[Morning or evening; What is the best time to take antihypertensive drugs?]Rik H G Olde Engberink, Bert-Jan H van den Born
Journal of Clinical Hypertension (Greenwich, Conn.)|November 1, 2019
Blood pressure lowering treatment and the Framingham score: Do not fear riskTom F Brouwer, Didier Collard, Bert-Jan H van den Born
JAMA Internal Medicine|October 5, 2018
Hydrochlorothiazide and the Risk of Malignant MelanomaBert-Jan H van den Born, Rik Olde-Engberink, Liffert Vogt
Journal of Human Hypertension|September 25, 2019
Effect of self-initiated and fully-automated self-measurement on blood pressureRosanne T Berkhof, Katia Gazzola, Bert-Jan H van den Born
European Heart Journal|April 8, 2025
Gut microbiota as predictors of recurrent cardiovascular events: challenges and future directionsBarbara J H Verhaar, Max Nieuwdorp, Bert-Jan H van den Born
Current Opinion in HIV and AIDS|August 9, 2017
Hypertension in people living with HIVRosan A van Zoest, Bert-Jan H van den Born, Peter Reiss
Circulation|June 6, 2018
Response by Kalkman et al to Letter Regarding Article, "J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm"Deborah N Kalkman, Tom F Brouwer, Bert-Jan H van den Born
Current Opinion in Lipidology|December 17, 2020
Impact drugs targeting cardiometabolic risk on the gut microbiotaManon Balvers, Bert-Jan H van den Born, Evgeni Levin, et al.
Pageof 20